
Free Daily Podcast Summary
by Hemish Ilangaratne
“Let’s Talk Quality” is a podcast that seeks to shine a light on quality assurance, a profession that acts as the cornerstone for bringing safer medicine to patients. For life science companies to continue to develop life-saving medicines, a culture of good quality must be driven across the industry, whether that be an early phase gene therapy biotech or a global pharma organisation. This podcast aims to drive that mission forward through inviting industry leaders, experts, and visionaries to share their knowledge, experiences, and strategies for achieving quality excellence. Join us on a journey of discovery as we unravel the importance of quality and its profound impact on businesses and society. Get ready to engage in insightful discussions, gain valuable perspectives, and unlock the secrets to fostering a culture of quality in every aspect of life.
The most recent episodes — sign up to get AI-powered summaries of each one.
Colleen Walson-Billin was told she was not eligible to progress in Quality without a science degree, and went on to lead a full GxP Quality function at a biologics startup.Colleen Walson-Billin on building a Quality career without a science degree.In today's episode I was joined by Colleen Walson-Billin, Vice President & Head of GxP Quality & Compliance at Jade Biosciences. I wanted to speak to Colleen because her route into Quality started with a business degree and a role as administrative assistant to a director of Quality at Amgen. From there she moved through QA, corporate and international Quality, served twice as chief of staff to the head of Quality, and now leads Quality across GMP, GCP, GLP and pharmacovigilance.We talk about:Starting in Quality as an administrative assistant, and telling her first boss up front that the role was her foot in the doorBeing told she was not eligible to progress without a science degree, and building her technical knowledge on the jobServing twice as chief of staff to the head of Quality, and what she learned at the table with the leadership teamLeaving Amgen for smaller companies, and picking up GCP, GLP and pharmacovigilance for the first timeLeading executive and senior directors, stepping back from being the doer, and positioning Quality as a partner from the startThank you Colleen for sharing your journey.Timestamps: Introduction "My foot in the door": business degree to admin assistant "You're just not even eligible" The advice that made the degree stop mattering A career with no plan, built by putting her hand up Leaving Amgen for a smaller company Employee number 24, and "enough to be dangerous" across GxP Why the degree becomes almost irrelevant at 20 years Roadblocks, naysayers and the police: old school Quality Selling Quality to a room of college students Inspired by what she did not want to become
Geetu Abbi was handed the GAMP guide as a new validation engineer at Genzyme, and in 2024 she co-led one.Geetu Abbi on When to Build a Digital Quality FunctionIn today's episode I was joined by Geetu Abbi, Head of Digital Quality Assurance at Alkermes. I wanted to speak to Geetu because Digital Quality was not a job title eight to ten years ago, and she has grown into the role from computer systems validation. She moved from software testing into validation at Siemens without a life sciences background, and in 2024 she co-led the GAMP guide for GCP and clinical trials.We talk about:- Moving from software testing into validation at Siemens, with no prior exposure to Part 11 or 21 CFR 820- What Digital Quality is, and the gap it fills between site Quality and clinical Quality- Data lifecycle mapping, and why validation now has to be revisited with every change- Delivering seven validated systems in eight months to support the Alkermes-Mural Oncology separation in 2023- Her advice to the next generation of Quality professionals on why they don't have to solve everything aloneThank you Geetu for sharing your journey.Timestamps: Introduction and guest background From QA to validation Career turning point What digital quality means Digital quality as a career opportunity How the team is structured Advice for future quality leaders
Naymisha (Isha) Patel has spent thirty years in Quality and regulatory compliance across pharmaceuticals, biologics, medical devices and combination products. She is now Senior Vice President of Quality at AirNexis Therapeutics, a seven-month-old startup developing a combination product for COPD, where she is the first Quality hire.In this episode Isha talks about the ten-year career plan she wrote overnight in 2005 after a hiring VP at Nektar asked what she wanted, and how it carried her from associate director to senior vice president. She explains why she moved to Boston in a blizzard to lead Quality at Ocular Therapeutix, a one-product company with two FDA complete response letters, and what she found in the inspection scribe notes. She walks through the reorganisation, letting go of people whose skill sets did not match the product classification, and the FDA inspection that ended in approval with no post-approval commitments. Isha also covers building Tenaya's Quality function, closing that same manufacturing facility four and a half years later, and choosing between consultants and permanent headcount.Topics covered:- Why a career plan written on paper beats a vague ambition- Reading the scribe notes, not just the CRL- Letting people go for skill fit, not performance- What FDA inspectors want to see when you are not finished- Green flags when a CEO hires their first head of Quality- Consultant or permanent hire: the two-year vision test- Why Quality is missing from early-stage boards- Quality as navigating grey zones, not yes or noTimestamps: Introduction and guest background Transitioning into Quality leadership Career moves and a pivotal opportunity A practical career plan Turning around a Quality system Building Quality in gene therapy Choosing the right startup role Building a lean Quality team C-suite and board aspirations Advice for aspiring Quality leaders
Dawn Houlihan started out as the person manufacturing teams went quiet around, and spent the next twenty years proving that quality works better as a partner than a police force.Dawn Houlihan on Her Journey From Ireland Big Pharma to the Boston Start-Up World In today's episode I was joined by Dawn Houlihan. I wanted to speak to Dawn because she has built a quality function from nothing, twice over, and has done it across almost every stage and modality the industry has to offer. She spent half her career with Janssen in Ireland, moved to Scotland and then to Boston, and has since led quality through phase three, commercial approval and cell and gene therapy in two small companies where everything was outsourced.We talk about:What quality was actually like on the manufacturing floor in Ireland in the mid two thousandsThe mentor who told her to say yes to a project she did not have time forSwitching CDMO in the middle of phase three and still hitting commercial approvalWhy saying no to everything is the easy road, and what it costs a small companyBeing the first quality hire at Ensoma and building the culture from scratchTimestamps: Introduction and Dawn's background in pharma Quality's evolution: from policing to partnership Mentorship, Scotland, and the move to Boston Building quality teams in biotech startups Trust, risk, and leading through partnership Building quality from the ground up The future of quality leadership and career advice
Luciana Mansolelli spent twenty years on the sponsor side. One question from a board chairman moved her to a CDMO.Luciana Mansolelli on her first year as CQO in the CDMO world.In today’s episode I was joined by Luciana Mansolelli, Chief Quality Officer at Minaris Advanced Therapies. I wanted to speak to Luciana because she has now led quality on both sides of the same relationship - Novartis and J&J on the sponsor side, and now a 200-person global quality organisation across the US, Germany and Japan.We talk about:• The moment she realised she had stopped learning, and why she left• Why framing speed against quality is the wrong model in advanced therapies• How she structured a global quality team around the science rather than the org chart• What she assesses for when she hires, beyond technical competence• Turnover in the CDMO world, and why she thinks capability is the fixThank you Luciana for sharing your journey.Timestamps: Introduction to Luciana Monsolelli Journey into Pharmaceutical Sciences The Evolution of Quality in Pharma Transitioning from Big Pharma to CDMO Challenges in the CDMO Landscape Building a Quality Culture at Minaris Talent Management and Capability Development Leadership Style and Team Dynamics Future Aspirations in Advanced Therapies
Season Four is at its halfway point, so instead of a guest this week I’ve gone back over the conversations so far and pulled out the theme that came up most often.The quality leader whose main function is to say no is finished. This episode is four clips from Season Four guests on that theme, with my own thoughts in between. I also talk about why I think this matters for your career and not just for your working relationships, which comes from the other half of my week, placing quality leaders and hearing what hiring managers are actually asking for.Get in touchIf you’re going through that step up at the moment, I’d be interested to hear about it. Find me on LinkedIn, or book a conversation here: https://calendly.com/h-ilangaratne/meeting-with-hemish-rx-groupIf there’s a topic you’d like covered on a future solo episode, send it over.Timestamps: - Intro - Halfway Through Season Four - The Old Reputation - Tim Mitchell - Hemish's Take - Reputation vs. Reality - Saying No Is the Easy Option - Kim Garko - Hemish's Take - The Career Angle - Translating Risk for the Business - Jamey Lindholm - Hemish's Take - Practical Application - Partnership Over Policing - Rex Ready - Closing Thoughts - What This Means for Quality Leaders
Quality culture isn't built by SOPs. It's built in the small moments when a leader reinforces the right behaviour or lets the wrong one slide.Speaking the Language of the Business, with Jamey Lindholm.In today's episode I was joined by Jamey Lindholm, Vice President of Quality at R1 Therapeutics. I really wanted to speak to Jamey because she has led Quality through nearly every stage a career in this industry can throw at you: a first-in-class FDA approval at Seres Therapeutics, an acquisition by Merck KGaA at Springworks, and now building a Quality function completely from zero as R1's very first Quality hire. She has strong, hard-won views on how to get each of those right.Jamey's journey started almost by accident. She fell into a QC chemistry job at a small biotech straight out of university, got laid off a year later when the company ran out of funding, and then spent the next 20 years at Biogen, where she built the foundation of what she now calls "what good looks like" in Quality. From there she moved to Seres Therapeutics, where she led end to end Quality through the first FDA approval of a microbiome-derived oral therapy, then to Springworks through its acquisition by Merck KGaA, and now to R1 Therapeutics as its first Quality hire.What comes through across the whole conversation is a leader who has thought deeply about the difference between compliance and culture. Jamey is clear that Quality earns its seat at the leadership table not by enforcing SOPs, but by translating compliance into risk, into regulatory consequence, into business decisions that leadership teams actually understand. She is equally clear that the industry has a visibility problem. Almost nobody chooses Quality as a career at school, and she believes that is something the industry has an obligation to fix.We talk about the following:Why 20 years at a large pharma company can make the move into a startup harder, not easierThe difference between managing Quality operations and being responsible for end-to-end Quality at a small companyWhy "quality risks are business risks" changes how a leadership team makes decisionsWhat actually builds quality culture, and why it isn't SOPsThe moment Seres received FDA approval for Vowst, and why it felt different from anything Jamey experienced at BiogenWhy it's never too early to bring in a permanent Head of Quality, and what that decision signals about a company's cultureWhy Quality is invisible as a career choice to STEM students, and what the industry can do about itJamey is a thoughtful, pragmatic quality leader who understands how to balance compliance, collaboration and business reality in complex development environments. If you are a quality professional working in an early-stage biotech and trying to build the right systems with limited resources, then this episode is for you. Thank you Jamey for sharing your incredible journey. Hope everyone enjoys the show.WHO THIS EPISODE IS FORA Head of Quality or VP Quality building a function from scratch at a startupA big pharma quality professional considering a move into biotechA founder or CEO deciding when to bring in a permanent Head of QualityA quality manager trying to build genuine culture, not just documentationA STEM student or early-career scientist who has never considered Quality as a career pathTimestamps: Introduction to Jamey Lindholm and Her Career Journey Transitioning from Big Pharma to Startups Navigating Quality in Complex Environments The Role of Quality in Business Strategy Building a Quality Culture in Startups Hiring for Quality in Startups The Visibility of Quality Careers in STEM Demystifying Quality for Future Generations Inspiring the Next Generation in Quality Science The Emotional Impact of FDA Approvals The Importance of Quality Leadership in Startups Building a Quality Culture from the Ground Up Advice for Future Quality Professionals Making the Case for a Career in Quality
Twenty years at Merck, then a leap into academia and psychedelic medicine - here is how Dawn Lundin built a quality career on instinct.Dawn Lundin on the big pharma habits you have to unlearn in a startup.In today's episode I was joined by Dawn Lundin, founder of her own quality consultancy and a fractional Head of Quality across biotech and psychedelic-medicine companies. I really wanted to speak to Dawn because her path is nothing like the typical quality leader's. She didn't stay inside big pharma and climb one ladder. She spent twenty years at Merck, then walked into academia, then into one of the most stigmatised fields in medicine, and she made each move work.Dawn started as a bench chemist and grew through GLP, clinical packaging, GCP auditing and pharmacovigilance, eventually heading up issues management and co-authoring the first quality manual for Merck's research division. Then, on the morning of her twentieth anniversary, she resigned. She moved to the University of Pennsylvania to build fit for purpose quality systems for both sponsor and site research, a system still in use today. From there she stepped into psychedelic medicine for mental health, a move driven as much by personal loss as by professional curiosity.What runs through Dawn's whole story is a refusal to lead by importing an old playbook. In a smaller, faster environment she learned to do quality with far less, to put relationships before procedures, and to build trust before she changed a single thing. Her line for it has stuck with me: she did quality "one cup of coffee at a time."We talk about the following:Why she left twenty years at Merck on the exact morning of her anniversaryThe big pharma habits leaders have to unlearn in academia and startupsHow to build a fit for purpose quality system with a fraction of the resourcesWhy relationships, not procedures, carry a quality programme in a small organisationThe personal story that drew her into psychedelic medicine and mental healthDawn Lundin is a thoughtful, pragmatic quality leader who understands how to balance compliance, collaboration and business reality in complex development environments. If you are a quality professional working in an early-stage biotech and trying to build the right systems with limited resources, then this episode is for you. Thank you Dawn for sharing your incredible journey. Hope everyone enjoys the show.WHO THIS EPISODE IS FORQuality leaders moving from big pharma into a startup, scale-up or academiaHiring managers building a first quality team and weighing up big pharma candidatesEarly-stage biotech founders who need fit for purpose quality without the overheadQuality professionals weighing a bold or unconventional career moveAnyone drawn to how mental health and psychedelic medicine are being built responsiblyTimestamps: - Introduction to Dawn Lundin - Dawn's Journey into Science and Quality - Career Growth at Merck - Transitioning from Big Pharma to Academia - Navigating Startup Challenges - Current Consultancy and Future Aspirations
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

Let's Talk Offline
Two career experts discuss real talk on work-life balance, pay negotiation, and office relationships for early-career professionals.

Smart Talks with IBM
Conversations with leaders leveraging AI, quantum computing, and emerging technologies to transform global businesses.

The Engineering Leadership Podcast
Insights and practices from top software engineering leaders to advance leadership skills in the tech industry.

The Peter Attia Drive
Conversations with experts on health, longevity, performance, and critical thinking led by physician Peter Attia.

Walk-In Talk Podcast
Raw conversations with food industry professionals about restaurant operations, culinary leadership, and the business of hospitality.

Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.

Lenny's Podcast: Product | Career | Growth
Conversations with top product and growth leaders offering practical strategies for building, launching, and scaling successful products.

HBR IdeaCast
Features leading thinkers in business and management discussing key ideas and trends.

The Balanced, Beautiful and Abundant Show - Rebecca Whitman
A coach helps high-achieving women overcome burnout using a framework centered on spiritual, emotional, physical, and financial well-being.

Treated with Dr. Sara Szal
Dr. Sara Szal explores holistic health solutions through conversations with experts and patients seeking mind, body, and soul healing.

Working Hard with Grace Beverley
Real people share hard-won lessons on success, resilience, and life balance across diverse fields, from activism to business and beyond.

Think Fast Talk Smart: Communication Techniques
Communication techniques from Stanford lecturer Matt Abrahams and experts to improve clarity, confidence, and impact in professional settings.
“Let’s Talk Quality” is a podcast that seeks to shine a light on quality assurance, a profession that acts as the cornerstone for bringing safer medicine to patients. For life science companies to continue to develop life-saving medicines, a culture of good quality must be driven across the industry, whether that be an early phase gene therapy biotech or a global pharma organisation. This podcast aims to drive that mission forward through inviting industry leaders, experts, and visionaries to share their knowledge, experiences, and strategies for achieving quality excellence. Join us on a journey of discovery as we unravel the importance of quality and its profound impact on businesses and society. Get ready to engage in insightful discussions, gain valuable perspectives, and unlock the secrets to fostering a culture of quality in every aspect of life.
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Let's Talk Quality in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Let's Talk Quality as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Hemish Ilangaratne.
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
Let's Talk Quality publishes weekly. Our AI generates a summary within hours of each new episode.
Let's Talk Quality covers topics including Science, Business, Management, Careers, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.